Tailored cancer therapy tested for patients who've run out of options
NCT ID NCT06024603
First seen Feb 17, 2026 · Last updated May 16, 2026 · Updated 11 times
Summary
This study explores whether personalized treatment recommendations based on lab tests of a patient's own tumor can be made within 4 weeks for adults with relapsed or refractory cancers who have no standard curative options. Researchers will use drug sensitivity testing and genetic profiling to suggest therapies. The goal is to see if this approach is feasible and may improve treatment response compared to usual care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Florida International University
Miami, Florida, 33199, United States
-
Lerner College of Medicine, Cleveland Clinic Florida
Weston, Florida, 33331, United States
Conditions
Explore the condition pages connected to this study.